Scholarlink

Background <p>Liposomes coated with fibrinogen γ-chain (HHLGGAKQAGDV, H12) peptide and encapsulating adenosine-diphosphate (ADP) [H12-(ADP)-liposomes] can augment platelet aggregation via glycoprotein IIb/IIIa receptors displayed on activated platelets. H12-(ADP)-liposomes release ADP, which is metabolized into adenosine that has tissue-protective effects. This study evaluated the life-saving efficacy of post-treatment with H12-(ADP)-liposomes in rats with LPS-induced coagulopathy and critical organ injuries.</p> Methods <p>LPS (10&#xa0;mg/kg) was administered intraperitoneally to rats. The rats were then treated with an intravenous injection of either H12-(ADP)-liposomes or normal saline (vehicle control) 4&#xa0;h later.</p> Results <p>Post-treatment with H12-(ADP)-liposomes significantly shortened the coagulation time compared to the vehicle treatment at 8&#xa0;h after LPS challenge and reduced expression of CD62P, a marker of platelet activation, on CD61<sup>+</sup> platelets at 12&#xa0;h. H12-(ADP)-liposome post-treatment also normalized the elevated levels of neutrophil elastase (complex) at 6–24&#xa0;h and citrullinated histone H3 in bronchoalveolar lavage fluid at 24&#xa0;h. H12-(ADP)-liposome-treated rats showed reductions in the pathological injury score for the lungs and kidneys at 8&#xa0;h. The survival rates of rats given H12-(ADP)-liposomes were markedly improved 24&#xa0;h after LPS challenge relative to vehicle-treated rats (50% vs. 21%, <i>p</i> = 0.038).</p> Conclusions <p>These findings suggest that post-treatment with H12-(ADP)-liposomes ameliorates LPS-induced coagulopathy and neutrophil activation, thereby improving critical organ injuries and survival in LPS-challenged rats.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Post-treatment with H12-(ADP)-liposomes after LPS challenge ameliorated coagulopathy and critical organ injury in rats

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月8日

查看全文
  • Kohsuke Hagisawa,
  • Osamu Ishida,
  • Hiroyuki Nakashima,
  • Shinji Takeoka,
  • Yuji Morimoto,
  • Manabu Kinoshita

摘要

Background

Liposomes coated with fibrinogen γ-chain (HHLGGAKQAGDV, H12) peptide and encapsulating adenosine-diphosphate (ADP) [H12-(ADP)-liposomes] can augment platelet aggregation via glycoprotein IIb/IIIa receptors displayed on activated platelets. H12-(ADP)-liposomes release ADP, which is metabolized into adenosine that has tissue-protective effects. This study evaluated the life-saving efficacy of post-treatment with H12-(ADP)-liposomes in rats with LPS-induced coagulopathy and critical organ injuries.

Methods

LPS (10 mg/kg) was administered intraperitoneally to rats. The rats were then treated with an intravenous injection of either H12-(ADP)-liposomes or normal saline (vehicle control) 4 h later.

Results

Post-treatment with H12-(ADP)-liposomes significantly shortened the coagulation time compared to the vehicle treatment at 8 h after LPS challenge and reduced expression of CD62P, a marker of platelet activation, on CD61+ platelets at 12 h. H12-(ADP)-liposome post-treatment also normalized the elevated levels of neutrophil elastase (complex) at 6–24 h and citrullinated histone H3 in bronchoalveolar lavage fluid at 24 h. H12-(ADP)-liposome-treated rats showed reductions in the pathological injury score for the lungs and kidneys at 8 h. The survival rates of rats given H12-(ADP)-liposomes were markedly improved 24 h after LPS challenge relative to vehicle-treated rats (50% vs. 21%, p = 0.038).

Conclusions

These findings suggest that post-treatment with H12-(ADP)-liposomes ameliorates LPS-induced coagulopathy and neutrophil activation, thereby improving critical organ injuries and survival in LPS-challenged rats.